期刊文献+

胃癌扩散加权成像ADC值与EGFR、Ki-67表达的相关性 被引量:6

Correlation of ADC value of MR diffusion-weighted magnetic resonance imaging with EGFR and Ki-67 expression in gastric cancer
下载PDF
导出
摘要 目的:初步探讨胃癌磁共振扩散加权成像(DWI)表观扩散系数(ADC)值与表皮生长因子受体(EGFR)、Ki-67表达的相关性。方法:回顾性分析68例胃癌患者的临床及MRI资料,同时采用免疫组化法检测胃癌中EGFR及Ki-67的表达,分析ADC值(包括平均ADC值和最小ADC值)与EGFR、Ki-67表达的关系。结果:平均ADC值及最小ADC值在不同EGFR表达状态中差异均有统计学意义(P<0.05),其中EGFR表达中阴性组的平均ADC值和最小ADC值均高于EGFR阳性组[(1.106±0.196)×10^(-3) mm^2/s和(0.918±0.164)×10^(-3) mm^2/s,P<0.001;(0.989±0.198)×10^(-3) mm^2/s和(0.835±0.170)×10^(-3) mm^2/s,P=0.002]。EGFR表达与平均ADC值、最小ADC值间均存在显著相关性(r=-0.432,P<0.001;r=-0.382,P=0.001),而Ki-67表达与ADC值间无明显相关性(P>0.05)。结论:胃癌ADC值与肿瘤细胞EGFR表达间存在相关性,ADC值有望作为临床治疗胃癌时辅助评估EGFR表达的指标。 Objective:To preliminarily investigate the correlation of apparent diffusion coefficient(ADC)value acquired from MR diffusion-weighted imaging(MR DWI)with molecular markers(EGFR and Ki-67)in patients with gastric cancer.Methods:The clinical and MRI materials of 68 patients with gastric cancer were analyzed retrospectively,EGFR and Ki-67 expression by immunohistochemistry were acquired simultaneously.Correlation between ADC values,including the mean and minimal ADC value,and EGFR,Ki-67 expression were analyzed,respectively.Results:There were significant differences in ADC values(mean and minimal)with different status of EGFR expression(P〈0.05).In EGFR-negative group,the mean and minimal ADC value were significantly higher than those of EGFR-positive group,respectively[(1.106±0.196)×10^-3 mm^2/s vs(0.918±0.164)×10^-3 mm^2/s,P〈0.001;(0.989±0.198)×10^-3 mm^2/s vs(0.835±0.170)×10^-3 mm^2/s,P= 0.002].The mean and minimal ADC value correlated significantly with EGFR expression,respectively(r=-0.432,P〈0.001;r=-0.382,P=0.001).However,there was no significant difference between Ki-67 expression and ADC value(P〉0.05).Conclusion:Correlation do exist between ADC values and EGFR expression;ADC value might be used as a noninvasive biological marker to evaluate the EGFR expression in clinical treatment of gastric cancer.
出处 《放射学实践》 北大核心 2017年第9期923-926,共4页 Radiologic Practice
基金 国家自然科学基金资助项目(81371516)
关键词 胃肿瘤 磁共振成像 扩散加权成像 受体 表皮生长因子 KI-67抗原 Stomach neoplasms Magnetic resonance imaging Diffusion weighted imaging Apparent diffusion coefficient Receptor Epidermal growth factor Ki-67 antigen
  • 相关文献

参考文献5

二级参考文献83

  • 1Nawfal R Hussein.Helicobacter pylori and gastric cancer in the Middle East: A new enigma?[J].World Journal of Gastroenterology,2010,16(26):3226-3234. 被引量:3
  • 2张晓鹏,唐磊,孙应实,李洁,曹崑.胃癌MR扩散加权成像扩散敏感因子的选择及其与常规序列的对照研究[J].中华放射学杂志,2007,41(12):1339-1343. 被引量:25
  • 3International Agency for Research on Cancer. Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in2012. [EB/OL]. [2013-12-12]. http://globocan, iare. fr/ Pages/fact_sheets_cancer. aspx. 被引量:1
  • 4Bang Y J, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophage- al junction Cancer (TOGA) : a phase 3, open-label, randomised controlled trial[ J]. Lancet, 2010, 376(9742) : 687-697. 被引量:1
  • 5Hofmann M, Stoss O, Shi D, et al. Assessment of a HER2 sco- ring system for gastric Cancer: results from a validation study [ Jl. Histopathology, 2008, 52 (7) : 797-805. 被引量:1
  • 6Won E, Janjigian YJ, llson DH. HER2 directed therapy for gas- trie/esophageal cancers [ J ]. Curr Treat Options Oncol, 2014,15(3) : 395--404. 被引量:1
  • 7Scartozzi M, Giampieri R, Del Prete M, et al. Selected gastroin- testinal cancer presentations from the American Society of Clini- cal Oncology annual meeting 2013 in review: it is not about the destination, it is about the journey[ J]. Expert opin pharmacoth- er, 2014, 15(1) : 143-150. 被引量:1
  • 8Kiyose S, Nagura K, Tao H, et al. Detection of kinase amplifi- cations in gastric Cancer archives using fluorescence in situ hy- bridization[J]. Pathol Int, 2012, 62(7) : 477-484. 被引量:1
  • 9Kim MA, Lee HS, Lee HE, et al. EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number[Jl. Histopathology, 2008, 52(6) : 738-746. 被引量:1
  • 10Lordick F, Kang YK, Chung HC, et al. Capeeitabine and cispl- atin with or without eetuximab for patients with previously un- treated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial[J]. Lancet Oncol, 2013, 14(6) : 490- 499. 被引量:1

共引文献115

同被引文献80

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部